RESEARCH & INNOVATION GOING FORWARD

Meet Nathan Lewis

Education:

Postdoctoral Fellow - Harvard Medical School
Ph.D. - Bioengineering, University of California, San Diego
M.S. - Bioengineering, University of California, San Diego
B.S. - Biochemistry, Brigham Young University

Professional Appointments:

2024 - Georgia Research Alliance Eminent Scholar, Department of Biochemistry and Molecular Biology, University of Georgia
2023 - Professor, Departments of Pediatrics and Bioengineering, University of California, San Diego
2023 - Visiting Professor, Department of Bioengineering, Technical University of Denmark
2021 – Co-founder, Augment Biologics
2021 – Co-founder, NeuImmune
2018 - Associate Professor, Departments of Pediatrics and Bioengineering, University of California, San Diego
2014 - Assistant Professor, Departments of Pediatrics and Bioengineering, University of California, San Diego
2013 - Assistant Professor, Department of Biology, Brigham Young University

Highlights:

2020-2023 - Otto Mønsted Foundation Gæsteprofessorater Fellow
2012 - Siebel Scholar
2008 - Fullbright Fellow

Transforming medicine by decoding how cells interact

When I think of any living organism, I don’t think of it as a lone entity. Each person, each plant, each animal, and even each cell is intricately connected to each other through molecular interactions. Meanwhile, each cell is also fueled, maintained, and functions because of myriad chemical reactions inside. This complexity of life has always fascinated me. My passion is understanding these complex molecular systems to solve health and environmental problems.

The challenge is the number of systems at play. It’s hard to manage even a few systems in our minds when considering these interactions. So we are developing powerful technologies to measure the various molecules and quantify how they interact.

I’m focused on pushing the boundaries of computational models to improve biomanufacturing, drug development, and biomedical discoveries. My team and I make great efforts to piece together decades of research from other scientists, ultimately building large and complex models. We integrate them into AI and machine learning algorithms to fill the gaps of missing knowledge. This work has helped us and others to engineer better cell factories for diverse medications, identifying new therapeutic targets, and deciphering the complex bases of conditions such as autism spectrum disorder and necrotizing enterocolitis, a life-threatening intestinal condition that affects premature infants.

I joined the University of Georgia in 2024 because it is home to one of the largest concentrations of glycobiologists in the nation—and possibly the world—focused on studying the complex carbohydrates that cover cells. Plus, the university has built excellent facilities for biomanufacturing and developing regenerative medicine. The atmosphere at UGA is strong and supportive. My colleagues and collaborators share a vision to join efforts toward meaningful, impactful research.

“Understanding the complex interaction between cells can transform medicine and power new biotech solutions, leading to potent, safe, economical, and sustainable therapeutics.”

Nathan Lewis, GRA Eminent Scholar, Professor of Biochemistry and Molecular Biology

Related Stories